R&D Systems™ Recombinant Human IL-31RA Protein, CF

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity

Supplier:  R&D Systems™ 2769IL050

Catalog No. 2769IL050

Description

The Recombinant Human IL-31 RA Protein is derived from NS0. The Recombinant Human IL-31 RA Protein has been validated for the following applications: Binding Activity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Molecular Weight (g/mol): 57.5 kDa
• Purity: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Source: Mouse myeloma cell line,NS0-derived human IL-31 RA protein Ala20-Ser516,with a C-terminal 6-His tag
• Gene Alias: class I cytokine receptor, CRL3, CRL3Glmr, Cytokine receptor-like 3, GLMR, GLM-R, GLM-RMGC125346, GP130 like receptor, Gp130-like monocyte receptor, Gp130-like receptor, hGLM-R, IL-31 RA, IL-31 receptor subunit alpha, IL-31R subunit alpha, IL31RA, IL-31RAGPLCRL, IL-31R-alpha, interleukin 31 receptor A, interleukin-31 receptor subunit alpha, PRO21384, soluble type I cytokine receptor CRL3, ZcytoR17
• Recombinant: Yes

• Gene ID (Entrez): 133396
• Name: IL-31RA
• Quantity: 50μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated